ProPhase Labs, Inc.

NASDAQ:PRPH

1.43 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 44.384122.64779.04214.5149.87613.1269.86721.01420.60422.0725.03222.40617.45314.50219.81620.50739.47542.12553.65843.94841.49929.42124.6719.36424.836.470.20.8
Cost of Revenue 28.14551.99346.2289.9087.2618.3457.91910.9488.4267.8918.3618.1546.1715.6728.2479.09416.82719.24725.82423.57321.48817.2099.6155.8857.710.721.30
Gross Profit 16.23970.65432.8144.6062.6154.7811.94810.06612.17814.17916.67114.25211.2828.8311.56911.41322.64822.87827.83420.37520.01112.21215.05413.4817.125.748.90.8
Gross Profit Ratio 0.3660.5760.4150.3170.2650.3640.1970.4790.5910.6420.6660.6360.6460.6090.5840.5570.5740.5430.5190.4640.4820.4150.610.6960.690.7060.6971
Reseach & Development Expenses 1.4180.6520.520.6330.3320.3980.4310.5751.0781.3220.8241.3011.0880.7941.3084.2426.493.823.7843.2333.3662.6631.3321.1860000
General & Administrative Expenses 34.50246.40722.4936.6714.484.914.8085.0636.9868.1435.8936.1275.0286.0549.344-5,944.13-5,957.9640000014.14918.22923.915.813.51.5
Selling & Marketing Expenses 1.932001.2871.0421.1070.6997.0847.6988.9659.5388.9467.9045.5764.8525,958.0315,977.35800000000000
SG&A 36.43446.40722.4937.9585.5226.0175.50712.14714.68417.10815.43115.07312.93211.6314.19613.90119.39421.4521.0716.9616.0114.83314.14918.22923.915.813.51.5
Other Expenses 0.0146.40706.6714.484.910.155.0636.98605.8935.103009.3440000-0.00200000.20.20.10
Operating Expenses 37.85247.05923.0138.5915.8546.4155.93812.72215.76218.4316.25516.37414.0212.42415.50418.14325.88425.2724.85520.19119.37617.49615.4819.41524.11613.61.5
Operating Income -21.61323.5959.801-3.985-3.239-1.634-3.99-2.656-3.584-7.8280.416-1.098-2.738-3.594-3.935-6.73-3.236-2.3922.9790.1820.636-5.284-0.426-5.935-79.735.3-0.7
Operating Income Ratio -0.4870.1920.124-0.275-0.328-0.124-0.404-0.126-0.174-0.3550.017-0.049-0.157-0.248-0.199-0.328-0.082-0.0570.0560.0040.015-0.18-0.017-0.306-0.2820.2660.503-0.875
Total Other Income Expenses Net -1.187-0.687-4.4961.6590.1330.1670.15-0.212-0.016-3.577-0.0111.0240.0280.0530.0090.320.7780.7320.3020.1990.0930.1520.40500.91.400
Income Before Tax -22.822.9085.305-2.326-3.106-1.467-3.663-2.868-3.6-7.8340.405-1.091-2.71-3.541-3.926-6.41-2.458-1.663.2820.4530.729-5.132-0.0210-6.111.235.30
Income Before Tax Ratio -0.5140.1870.067-0.16-0.314-0.112-0.371-0.136-0.175-0.3550.016-0.049-0.155-0.244-0.198-0.313-0.062-0.0390.0610.010.018-0.174-0.0010-0.2460.3080.5030
Income Tax Expense -6.0184.445-0.9680.094-0.0930.103-17.990.2120.0163.5830.011-1.031-0.028-0.04-0.084-1.196-0.7780.0890.065-0.269-0.0391.17-0.642-0.739-1.94.414.30.7
Net Income -16.78218.4636.273-2.42-3.013-1.7441.831-2.868-3.6-7.8340.405-1.091-2.71-3.501-3.842-5.534-2.458-1.7483.2170.4530.675-6.4540.216-5.196-4.26.821-0.7
Net Income Ratio -0.3780.1510.079-0.167-0.305-0.1334.239-0.136-0.175-0.3550.016-0.049-0.155-0.241-0.194-0.27-0.062-0.0420.060.010.016-0.2190.009-0.268-0.1690.1870.299-0.875
EPS -0.981.170.41-0.21-0.26-0.152.61-0.17-0.22-0.470.03-0.074-0.18-0.25-0.3-0.43-0.19-0.140.280.040.06-0.590.02-0.49-0.370.511.72-0.17
EPS Diluted -0.981.020.4-0.21-0.26-0.152.59-0.17-0.22-0.470.03-0.074-0.18-0.25-0.3-0.43-0.19-0.140.240.030.05-0.590.02-0.49-0.370.461.43-0.17
EBITDA -14.91528.80914.006-3.465-2.841-1.634-3.609-2.229-3.584-4.2470.661-3.146-2.383-3.231-3.944-5.986-2.24-1.0654.3840.6071.109-4.8750.064-5.57-7.78.535.4-0.7
EBITDA Ratio -0.3360.2350.177-0.239-0.288-0.124-0.366-0.106-0.174-0.1920.026-0.14-0.137-0.223-0.199-0.292-0.057-0.0250.0820.0140.027-0.1660.003-0.288-0.310.2340.504-0.875